Meet Our Experts

Please select a topic:

Experts for: R&D Strategies

Daniel Sehrt

Daniel Sehrt

Expert for Early Clinical Research & Development

  • Scientific concept & design of Phase I-IIa trials
  • Clinical pharmacology (PK/PD and pharmacogenomics)
  • Clinical trial applications
Christian Wolf

Christian Wolf

Expert for Clinical Development & Life Cycle Management

  • CNS indications (MS, epilepsy, stroke)
  • Strategy, operations and interim management
  • Business development
Bernd Schmidt

Bernd Schmidt

Expert for neuropsychiatric drug development

  • preclinical and clinical (Ph I-IV) drug development
  • regulatory support, interim management
  • positioning, market access
Frank S. Zollmann

Frank S. Zollmann

Expert for Pre-/ Clinical Drug Development

  • Safety pharmacology, toxicology, pharmacogenomics
  • Integrated preclinical & clinical development up to PoC
  • Clinical pharmacology
Johannes Lampe

Johannes Lampe

Expert for Clinical Research & Development

  • Clinical development, Phase I-IV (Neurology, Immunology)
  • Medical regulatory strategy
  • Due diligence
Wolf-Stefan Richter

Wolf-Stefan Richter

Expert for Clinical Development

  • Study design and imaging biomarkers
  • Medical need assessment
  • Medical regulatory strategy
Erwin Böhm

Erwin Böhm

Expert for Clinical Research & Development

  • Translational Medicine
  • Clinical Development Phase I-III (Dermatology, Cardiovascular, Oncology)
  • Interim Management
Astrid Schott

Astrid Schott

Expert for Clinical Research & Development

  • Clinical Development planning, Phase I-III
  • Interim management
  • Due Diligence, licensing